AlphaGrep UK Ltd’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
AlphaGrep UK Ltd's ELV Position: Q1 2026 in Review
AlphaGrep UK Ltd increased its Elevance Health (ELV) stake by 122% in Q1 2026, buying an estimated $357K and bringing the position to 1,974 shares worth $578K. The position accounts for 0.17% of the portfolio, ranked #178.
AlphaGrep UK Ltd first reported a position in ELV in Q4 2025 and has held it in 2 quarters since. 1,468 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- AlphaGrep UK Ltd held 1,974 shares of Elevance Health worth $578K as of Q1 2026.
- AlphaGrep UK Ltd bought 1,085 Elevance Health shares in Q1 2026, an estimated $357K.
- Elevance Health made up 0.17% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #178 holding.
- AlphaGrep UK Ltd first reported a position in Elevance Health in Q4 2025 and has held it in 2 quarters since.
- 1,468 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.